Anzeige
Mehr »
Freitag, 19.12.2025 - Börsentäglich über 12.000 News
+15% an einem Tag - und dieser Ausbruch hat gerade erst begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 895878 | ISIN: US7611521078 | Ticker-Symbol: RME
Tradegate
19.12.25 | 18:10
208,90 Euro
+0,97 % +2,00
Branche
Gesundheitswesen
Aktienmarkt
S&P 500
1-Jahres-Chart
RESMED INC Chart 1 Jahr
5-Tage-Chart
RESMED INC 5-Tage-Chart
RealtimeGeldBriefZeit
209,00209,4018:51
209,00209,4018:51

Aktuelle News zur RESMED Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
RESMED Aktie jetzt für 0€ handeln
DoResMed stock price target lowered to $260 by Stifel on Philips return concerns16
DiTandem Diabetes upgraded, Zimmer, ResMed downgraded as Baird previews MedTech in 20264
DiBaird stuft ResMed-Aktie wegen Wachstumssorgen auf "Neutral" herab17
DiBaird downgrades ResMed stock rating to Neutral on slowing growth7
12.12.UBS erhöht Kursziel für ResMed auf 345 US-Dollar4
09.12.RESMED INC: 4 Statement of changes in beneficial ownership2
09.12.RESMED INC: 144 Report of proposed sale of securities1
08.12.Resmed Gets FDA Clearance For Personalized Therapy Comfort Settings; To Be Marketed As Smart Comfort492WASHINGTON (dpa-AFX) - Resmed (RMD, RMD.AX), Monday announced it has received U.S. Food and Drug Administration (FDA) clearance for Personalized Therapy Comfort Settings (PTCS), to be marketed...
► Artikel lesen
08.12.Resmed wins FDA clearance for AI-enabled personalized CPAP therapy device3
08.12.Resmed, Inc.: Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy281SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has...
► Artikel lesen
08.12.Is ResMed Stock Underperforming the S&P 500?5
05.12.Healthcare & Biotech Stocks Rally After Hours: Sensei, Praxis, Cooper, Vanda, Cue, ResMed463WASHINGTON (dpa-AFX) - Several healthcare and biotech names posted notable gains in Thursday's after-hours session, driven by clinical updates, earnings results, and regulatory developments.Sensei...
► Artikel lesen
04.12.RESMED INC: 4 Statement of changes in beneficial ownership1
04.12.RESMED INC: 144 Report of proposed sale of securities-
03.12.RESMED INC: Statement of CDIs on issue - RMD6
02.12.RESMED INC: 144 Report of proposed sale of securities-
01.12.RESMED INC: 144 Report of proposed sale of securities-
27.11.Michael J Farrell Makes Strategic Play: Invests $179K In ResMed Stock Options9
27.11.PETER FARRELL At ResMed Acquires Stock Options Worth $7K19
26.11.RESMED INC: 4 Statement of changes in beneficial ownership11
Weiter >>
190 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1